Beaverton, OR (PRWEB) January 16, 2014
Sonivate Medical, Inc. and Fukuda Denshi USA announced today a strategic partnership to market and distribute the Sonivate SonicEye® finger probe with Fukuda Denshi ultrasound systems. The SonicEye® is a high-performance, finger-mounted probe that allows clinicians to use one finger to image while leaving both hands free to simultaneously perform procedures. That unique capability extends ultrasound to new applications and new clinical settings.
“We are putting patient care directly in the hands of physicians and clinicians with the SonicEye®,” said company founder, Ron Schutz MD, FACC. “The SonicEye® is a technological advancement that places Fukuda Denshi at the forefront of patient care and ultrasound innovation,” added Julie Davis, Ultrasound Business Development Manager for Fukuda Denshi USA.
The agreement allows for global distribution of SonicEye® with compatible Fukuda Denshi ultrasound systems.
About Sonivate Medical
Sonivate was founded by Dr. Ronald Schutz who brought a clinically focused approach to the development of the SonicEye® with the goal to enable the physician to create a higher level of care. The path to funding and product development was aided by a grant from the U.S. Military’s Telemedicine and Advanced Technology Research Center (TATRC), which is part of the US Army Medical Research and Material Command. In 2012, Sonivate obtained FDA clearance for the SonicEye® Probe.
For more information about Sonivate Medical, contact David Starr at 503-709-4384 or visit http://www.sonivate.com.
About Fukuda Denshi
With its headquarters in Tokyo, Japan, Fukuda Denshi is a world leader in Cardiology Instrumentation, Patient Monitoring and Ultrasound technologies with over $1B in sales last year. Since its inception more than half a century ago, the company has established distribution in the U.S. and Canada from its U.S. office in Redmond, Washington.
For more information about Fukuda Denshi, visit http://www.fukuda.com or call 800-365-6668.